{"id":"14c-glpg3667-capsule","_chembl":null,"modality":"Small molecule","_dailymed":null,"_scrapedAt":"2026-03-28T05:48:13.638Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123057,"model":"claude-sonnet-4-5-20250929"},"description":"[14C]-GLPG3667 capsule is a radiolabeled investigational compound developed by Galapagos NV for Phase 1 clinical studies. The carbon-14 labeling enables absorption, distribution, metabolism, and excretion (ADME) studies to track the drug's behavior in the human body and understand its pharmacokinetic profile.","indications":{"approved":[{"status":"investigational","condition":"ADME study in healthy volunteers","patientPopulation":"Healthy adult volunteers"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"[14C]-GLPG3667 capsule","genericName":"[14C]-GLPG3667 capsule","companyName":"Galapagos NV","companyId":"galapagos-nv","firstApprovalDate":"","aiSummary":"","enrichmentLevel":2,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}